Comparison of the effect of Melatonin and Clonazepam on the REM sleep behavior disorder of patients with Parkinson's disease
Phase 3
- Conditions
- REM sleep behavior disorder of patients with Parkinson's disease.Parkinson's disease
- Registration Number
- IRCT20170821035819N3
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with Parkinson's who have REM sleep disorder based on history and questionnaire
Exclusion Criteria
Dementia
A history of drug sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: First time and After 1 month. Method of measurement: Pittsburgh sleep quality questionnaire.;Daytime sleepiness. Timepoint: First time and After 1 month. Method of measurement: Epworth sleepiness score questionnaire.;REM Sleep Disorder. Timepoint: First time and After 1 month. Method of measurement: REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ).
- Secondary Outcome Measures
Name Time Method